Proteomics Intl Labs Ltd has released a press release.
Suspension from Official Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Modelling shows PromarkerD could save US payers $384 billion
- Proteomics secures major analytical services contract
- Major economic health benefit demonstrated for PromarkerD
- March 2021 Quarterly Activities Report and Appendix 4C
- ISO 13485 certification received - Manufacturing Update
Later from Proteomics International Laboratories
- Reinstatement to Official Quotation
- Study shows diabetes drug improves PromarkerD risk scores
- Proteomics engages Abcam to manufacture PromarkerD reagents
- June 2021 Quarterly Activities Report and Appendix 4C
- Proteomics to collaborate to validate test for endometriosis
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories